The present pharmacochemical and modelling work focused on a benzimidazolyl-chalcone series. These previously synthesized compounds were evaluated in vitro for their anticancer activities against a panel of seven human cancer cell lines and normal fibroblasts. Among the new benzimidazole-supported chalcones, nine (9) compounds (compounds 1 - 4, 6 - 8 and compounds 10 and 11) showed promising anticancer activities with IC50s ranging from 0.83 to 2.58 μM. Compounds 2 and 6 with IC50s of 0.83 and 0.86 μM, respectively, were shown to be potent inhibitors of HCT-116 colon cancer cell proliferation. It was therefore necessary, for a development of this new series of chalcones, to establish through a QSAR study, their quantum descriptors according to the DFT calculation method and following the B3LYP/6-31+G (d,p) theory. These descriptive and predictive studies focused on the colon HCT 116 cell line which was found to be more sensitive to the anticancer action of our benzimidazolyl-retrochalcones. QSAR study showed that the electronic energy (Eelec), lipophilicity (logP), chemical softness (S) and chemical hardness (η) of benzimidazolyl-retrochalcones play an important role in inhibiting cancer cell proliferation.
References
[1]
WHO (2020). https://www.who.int/fr/news-room/fact-sheets/detail/cancer
[2]
Torre, L.A., Bray, F., Siegel, R.L., Ferlay, J., Lortet-Tieulent, J. and Jemal, A. (2015) Global Cancer Statistics, 2012. CA: A Cancer Journal for Clinicians, 65, 87-108.
https://doi.org/10.3322/caac.21262
[3]
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D. and Bray, F. (2015) Cancer Incidence and Mortality Worldwide: Sources, Methods and Major Patterns in GLOBOCAN 2012. International Journal of Cancer, 136, E359-E386. https://doi.org/10.1002/ijc.29210
[4]
Stewart, B.W. and Wild, C.P. (2014) World Cancer Report 2014. International Agency for Research on Cancer, Lyon.
http://file:///C:/Users/Admin/Downloads/World%20Cancer%20Report%209789283204435.pdf
[5]
N’Guessan, K.N., Guy-Richard Koné, M., Bamba, K., Wawohinlin Patrice, O. and Ziao, N. (2017) Quantitative Structure Anticancer Activity Relationship (QSAR) of a Series of Ruthenium Complex Azopyridine by the Density Functional Theory (DFT) Method. Computational Molecular Bioscience, 7, 19-31.
https://doi.org/10.4236/cmb.2017.72002
[6]
N’Dri, J.S., Kablan, A.L., Ouattara, B., Koné, M.G., Ouattara, L.P., Kodjo, C.G. and Ziao, N. (2019) QSAR Studies of the Antifungal Activities of α-Diaminophosphonates Derived from Dapsone by DFT Method. Journal of Materials Physics and Chemistry, 7, 1-7.
[7]
Chen, M., Theander, T.G., Christensen, S.B., Hviid, L., Zhai, L. and Kharazmi, A. (1994) Licochalcone A, a New Antimalarial Agent, Inhibits in Vitro Growth of the Human Malaria Parasite Plasmodium falciparum and Protects Mice from P. yoelii Infection. Antimicrobial Agents and Chemotherapy, 38, 1470-1475.
https://doi.org/10.1128/AAC.38.7.1470
[8]
Boeck, P., Bandeira Falcão, C.A., Leal, P.C., Yunes, R.A., Filho, V.C., Torres-Santos, E.C. and Rossi-Bergmann, B. (2006) Synthesis of Chalcone Analogues with Increased Antileishmanial Activity. Bioorganic and Medicinal Chemistry, 14, 1538-1545.
https://doi.org/10.1016/j.bmc.2005.10.005
[9]
ElSohly, H.N., Joshi, A.S., Nimrod, A.C., Walker, L.A. and Clark, A.M. (2001) Antifungal Chalcones from Macluratinctoria. Plantamedica, 67, 87-89.
https://doi.org/10.1055/s-2001-10621
[10]
Boeck, P., Leal, P.C., Yunes, R.A., Filho, V.C., López, S., Sortino, M., Escalante, A., Furlán, R.L. and Zacchino, S. (2005) Antifungal Activity and Studies on Mode of Action of Novel Xanthoxyline-Derived Chalcones. Archiv der Pharmazie, 338, 87-95.
https://doi.org/10.1002/ardp.200400929
[11]
Haraguchi, H., Tanimoto, K., Tamura, Y., Mizutani, K. and Kinoshita, T. (1998) Mode of Antibacterial Action of Retrochalcones from Glycyrrhizainflata. Phytochemistry, 48, 125-129. https://doi.org/10.1016/S0031-9422(97)01105-9
[12]
Nielsen, S.F., Larsen, M., Boesen, T., Schønning, K. and Kromann, H. (2005) Cationic Chalcone Antibiotics. Design, Synthesis, and Mechanism of Action. Journal of medicinal chemistry, 48, 2667-2677. https://doi.org/10.1021/jm049424k
[13]
Kamal, A., Prabhakar, S., JanakiRamaiah, M., Venkat Reddy, P., Ratna Reddy, C.H., Mallareddy, A., Shankaraiah, N., Lakshmi Narayan Reddy, T., Pushpavalli, S.N. and Pal-Bhadra, M. (2011) Synthesis and Anticancer Activity of Chalcone-Pyrrolobenzodiazepine Conjugates Linked via 1,2,3-Triazole Ring Side-Armed with Alkane Spacers. European Journal of Medicinal Chemistry, 46, 3820-3831. https://doi.org/10.1016/j.ejmech.2011.05.050
[14]
Syam, S., Abdelwahab, S.I., Al-Mamary, M.A. and Mohan, S. (2012) Synthesis of Chalcones with Anticancer Activities. Molecules (Basel, Switzerland), 17, 6179-6195.
https://doi.org/10.3390/molecules17066179
[15]
Wei, H., Zhang, X., Wu, G., Yang, X., Pan, S., Wang, Y. and Ruan, J. (2013) Chalcone Derivatives from the Fern Cyclosorusparasiticus and Their Anti-Proliferative Activity. Food and Chemical Toxicology, 60, 147-152.
https://doi.org/10.1016/j.fct.2013.07.045
[16]
Abdel-Mohsen, H.T., Ragab, F.A., Ramla, M.M. and El Diwani, H.I. (2010) Novelbenzimidazole-Pyrimidine Conjugates as Potentantitumor Agents. European Journal of Medicinal Chemistry, 45, 2336-2344.
https://doi.org/10.1016/j.ejmech.2010.02.011
[17]
Garuti, L., Roberti, M. and De Clercq, E. (2002) Synthesis and Antiviral/Antiproliferative Activity of Some N-sulphonylbenzimidazoles. Bioorganic & Medicinal Chemistry Letters, 12, 2707-2710.
https://doi.org/10.1016/S0960-894X(02)00535-8
[18]
Hwu, J.R., Singha, R., Hong, S.C., Chang, Y.H., Das, A.R., Vliegen, I., De Clercq, E. and Neyts, J. (2008) Synthesis of New Benzimidazole-Coumarin Conjugates as Anti-Hepatitis C Virus Agents. Antiviral Research, 77, 157-162.
https://doi.org/10.1016/j.antiviral.2007.09.003
[19]
He, Y., Yang, J., Wu, B., Risen, L. and Swayze, E.E. (2004) Synthesis and Biological Evaluations of Novel Benzimidazoles as Potential Antibacterial Agents. Bioorganic & Medicinal Chemistry Letters, 14, 1217-1220.
https://doi.org/10.1016/j.bmcl.2003.12.051
[20]
Güven, O.O., Erdoğan, T., Göker, H. and Yildiz, S. (2007) Synthesis and Antimicrobial Activity of Some Novel Phenyl and Benzimidazole Substituted Benzyl Ethers. Bioorganic & Medicinal Chemistry Letters, 17, 2233-2236.
https://doi.org/10.1016/j.bmcl.2007.01.061
[21]
Mavrova, A., Anichina, K.K., Vuchev, D.I., Tsenov, J.A., Kondeva, M.S. and Micheva, M.K. (2005) Synthesis and Antitrichinellosis Activity of Some 2-substituted-[1,3]thiazolo[3,2-a]benzimidazol-3(2H)-ones. Bioorganic & Medicinal Chemistry, 13, 5550-5559. https://doi.org/10.1016/j.bmc.2005.06.046
[22]
Mavrova, A., Anichina, K.K., Vuchev, D.I., Tsenov, J.A., Denkova, P.S., Kondeva, M.S. and Micheva, M.K. (2006) Antihelminthic Activity of Some Newly Synthesized 5(6)-(un)substituted-1H-benzimidazol-2-ylthioacetylpiperazine Derivatives. European Journal of Medicinal Chemistry, 41, 1412-1420.
https://doi.org/10.1016/j.ejmech.2006.07.005
[23]
Göker, H., Kuş, C., Boykin, D.W., Yildiz, S. and Altanlar, N. (2002) Synthesis of Some New 2-Substituted-phenyl-1H-benzimidazole-5-carbonitriles and Their Potent Activity against Candida Species. Bioorganic & Medicinal Chemistry, 10, 2589-2596. https://doi.org/10.1016/S0968-0896(02)00103-7
[24]
Kone, A., Ouattara, M., Zon, D., Chany, A., Collet, S., Sissouma, D. and Adjou, A. (2018) Synthesis and Cytotoxic Activities of 3-Benzimidazolyl-Chalcones Derivatives. World Journal of Pharmaceutical Research, 7, 1589-1601.
[25]
Ouattara, M., Sissouma, D., Koné, M.W., Menan, H., Touré, S.A. and Ouattara, L. (2011) Synthesis and Anthelmintic Activity of Some Hybrid Benzimidazolyl-Chalcone Derivatives. Tropical Journal of Pharmaceutical Research, 10, 767-775.
https://doi.org/10.4314/tjpr.v10i6.10
[26]
Sissouma, D., Ouattara, M., Zon, D. and Kone, M.W. (2015) Synthesis and Antifungal Activities of Some Benzimidazolyl-Chalcones, Analogues of Chlormidazole. African Journal of Pharmacy and Pharmacology, 9, 418-423.
https://doi.org/10.5897/AJPP2014.4171
[27]
Ouattara, M., Sissouma, D., Yavo, W. and Kone, M.W. (2015) Synthèse et criblageantiplasmodial de quelquesbenzimidazolyl-chalcones. International Journal of Biological and Chemical Sciences, 9, 1697-1710.
https://doi.org/10.4314/ijbcs.v9i3.48
[28]
Songuigama, C., Jean-Paul, N.D., Mamidou, K.W., Drissa, S. and Mahama, O. (2018) Anti-Candidosi Activities of New Chalcones Vectorised by Benzimidazole against a Strain of Candida albicans Pharmacoresistance to Azoles. IOSR Journal of Pharmacy and Biological Sciences, 13, 11-16.
[29]
Songuigama, C., et al. (2019) Synthesis and Antifungal Activities of Benzimidazolyl-Arylpropenone Scaffolds as Promising Inhibitors of Azole-Resistant Candida Strains. European Journal of Biomedical and Pharmaceutical Sciences, 6, 19-25.
[30]
Mahama, O., Jean-Paul, N.D., Songuigama, C., Drissa, S. and Mamidou, K.W. (2020) Design and Pharmacochemical Development of New Anthelmintics with Benzimidazolyl Arylpropenone Profile: Structure-Activity Relationship. Pharmacophore, 11, 58-66.
[31]
Chatterjee, S., Hadi, A.S. and Price, B. (2000) Regression Analysis by Example. Wiley, New York.
[32]
ThiNgocPhuong Huynh (2007) Synthèse et études des relations structure/activité quantitatives (QSAR/2D) d’analyse benzo[c]phénanthridiniques. Sciences du Vivant [q-bio]. Universitéd’Angers, Français.
Chattaraj, P.K., Cedillo, A. and Parr, R.G. (1995) Variational Method for Determining the Fukui Function and Chemical Hardness of an Electronic System. The Journal of Chemical Physics, 103, 7645-7646. https://doi.org/10.1063/1.470284
[35]
Ayers, P.W. and Parr, R.G. (2000) Variational Principles for Describing Chemical Reactions: The Fukui Function and Chemical Hardness Revisited. Journal of the American Chemical Society, 122, 2010-2018. https://doi.org/10.1021/ja9924039
[36]
De Proft, F., Martin, J.M.L. and Geerlings, P. (1996) On the Performance of Density Functional Methods for Describing Atomic Populations, Dipole Moments and Infrared Intensities. Chemical Physics Letters, 250, 393-401.
https://doi.org/10.1016/0009-2614(96)00057-7
[37]
Geerlings, P., De Proft, F. and Martin, J.M.L. (1996) Recent Developments in Density Functional Theory. In: Seminario, J., Ed., Theoretical and Computational Chemistry, Elsevier, Amsterdam, Vol. 4, 773.
https://doi.org/10.1016/S1380-7323(96)80103-8
[38]
De Proft, F., Martin, J.M.L. and Geerlings, P. (1996) Calculation of Molecular Using Density Functional Methods. Chemical Physics Letters, 256, 400-408.
https://doi.org/10.1016/0009-2614(96)00469-1
[39]
De Proft, F. and Geerlings, P. (1997) Calculation of Ionization Energies, Electron Affinities, Electronegativities, and Hardnesses Using Density Functional Methods. The Journal of Chemical Physics, 106, 3270-3279. https://doi.org/10.1063/1.473796
[40]
Geerlings, P., De Proft, F. and Langenaeker, W. (1998) Density Functional Theory: A Source of Chemical Concepts and a Cost-Effective Methodology for Their Calculation. In: Advances in Quantum Chemistry, Elsevier, Amsterdam, Vol. 33, 303-328.
https://doi.org/10.1016/S0065-3276(08)60442-6
[41]
Parr, R.G., Donnelly, R.A., Levy, M. and Palke, W.E. (1978) Electronegativity: The Density Functional Viewpoint. The Journal of Chemical Physics, 68, 3801-3807.
https://doi.org/10.1063/1.436185
[42]
Hansch, C., Sammes, P.G. and Taylor, J.B. (1990) Computers and the Medicinal Chemist. In: Comprehensive Medicinal Chemistry, Pergamon Press, Oxford, Vol. 4, 33-58.
[43]
Franke, R. (1984) Theoretical Drug Design Methods. Elsevier, Amsterdam.
[44]
Microsoft® Excel® 2013 (15.0.4420.1017) MSO (15.0.4420.1017) 64 Bits (2013) Partie de Microsoft Office Professionnel Plus.
[45]
XLSTAT Version 19.5.47062 (64 bit) Copyright 1995-2018 (2018) XLSTAT and Adding software Registered Trademarks of Addinsoft. https://www.xlstat.com
[46]
Huheey, J.E. (1965) The Electronegativity of Groups. The Journal of Chemical Physics, 69, 3284-3291. https://doi.org/10.1021/j100894a011
[47]
Politzer, P. (1987) A Relationship between the Charge Capacity and the Hardness of Neutral Atoms and Groups. The Journal of Chemical Physics, 86, 1072-1073.
https://doi.org/10.1063/1.452296
[48]
Chattaraj, P.K., Cedillo, A. and Parr, R.G. (1996) Chemical Softness in Model Electronic Systems: Dependence on Temperature and Chemical Potential. Chemical Physics, 204, 429-437. https://doi.org/10.1016/0301-0104(95)00276-6
[49]
Lipinski, C.A., Lombardo, F., Dominy, B.W. and Feeney, P.J. (2001) Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings. Advanced Drug Delivery Reviews, 46, 3-26.
https://doi.org/10.1016/S0169-409X(00)00129-0
[50]
Vessereau, A. (1988) Méthodes statistiques en biologie et en agronomie. Tec et Doc Lavoisier, Paris.
[51]
Snedecor, G.W. and Cochran, W.G. (1967) Statistical Methods. Oxford and IBH, New Delhi.
[52]
Diudea, M.V. (2000) QSPR/QSAR Studies for Molecular Descriptors. Nova Science: Huntingdon, New York.
[53]
Esposito, E.X., Hopfinger, A.J. and Madura, J.D. (2004) Methods for Applying the Quantitative Structure-Activity Relationship Paradigm. In: Methods in Molecular Biology, Humana Press, Totowa, Vol. 275, 131-213.
https://doi.org/10.1385/1-59259-802-1:131
[54]
Eriksson, L., Jaworska, J., Worth, A.P., Cronin, M.T., McDowell, R.M. and Gramatica, P. (2003) Methods for Reliability and Uncertainty Assessment and for Applicability Evaluations of Classification- and Regression-Based QSARs. Environmental Health Perspectives, 111, 1361-1375. https://doi.org/10.1289/ehp.5758
